Ticagrelor in Patients With ST Elevation Myocardial Infarction Treated With Pharmacological Thrombolysis

NCT ID: NCT02298088

Last Updated: 2019-02-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

3799 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-08-31

Study Completion Date

2019-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Administration of Ticagrelor in patients with ST elevation myocardial infarction treated with pharmacological thrombolysis

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Phase III, Randomized, International, Multicenter, Open label, with Blinded Adjudication of Outcomes, Non-Inferiority Clinical Trial to Explore the Safety and Efficacy of Ticagrelor Compared with Clopidogrel in Patients with Acute Coronary Syndrome with ST Elevation Treated with Pharmacological Thrombolysis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute ST Segment Elevation Myocardial Infarction Thrombolysis in Myocardial Infarction Flow

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Blinded adjudication

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Ticagrelor 180 mg

Patients assigned to Ticagrelor will receive oral Ticagrelor, 180 mg as early as possible after the index event and not \>24 h post event followed by 90 mg twice daily for 12 months.

Group Type ACTIVE_COMPARATOR

Ticagrelor 180 mg

Intervention Type DRUG

Ticagrelor, 180 mg as early as possible after the index event and not \>24 h post event followed by 90 mg twice daily for 12 months.

Clopidogrel

Patients will take the 300 mg clopidogrel as early as possible after the index event and not \> 24h post event, followed by 75mg/day for 12 months.

For patients with \> 75 years the recommended load dose is 75 mg instead 300 mg.

Group Type ACTIVE_COMPARATOR

Clopidogrel

Intervention Type DRUG

300 mg clopidogrel as early as possible after the index event and not \> 24h post event, followed by 75mg/day for 12 months.

For patients with \> 75 years the recommended load dose is 75 mg instead 300 mg.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ticagrelor 180 mg

Ticagrelor, 180 mg as early as possible after the index event and not \>24 h post event followed by 90 mg twice daily for 12 months.

Intervention Type DRUG

Clopidogrel

300 mg clopidogrel as early as possible after the index event and not \> 24h post event, followed by 75mg/day for 12 months.

For patients with \> 75 years the recommended load dose is 75 mg instead 300 mg.

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Ticagrelor

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients of both sexes aged ≥ 18 years and \< 75 years with ACS with ST segment elevation with onset during the previous 24 hours, documented by cardiac ischemic symptoms due to atherosclerosis of \> 10 minutes duration at rest, treated with pharmacological thrombolysis
* Fibrinolytic therapy should be given to patients with STEMI and onset of ischemic symptoms within the previous 12 hours

Patients with acute coronary syndrome with ST segment elevation will be included provided they present ST segment elevation at the J point in two contiguous leads in electrocardiogram with cut-points: \> 0.1mV in all leads other than leads V2-V3, where the following cut points apply: \> 0.2 mV in men \> 40 years; \> 0.25 mV in men \< 40 years, or \>0.15 mV in women and at least 1 of the following criteria:

* Angina-like chest pain or ischemic equivalent chest pain;
* Abnormalities above the reference value for markers of myocardial necrosis (troponin and CK-MB).

The patient must be able to give informed consent in accordance with ICH GCP guidelines and local legislation and/or regulations.

Exclusion Criteria

* Any contraindication against the use of clopidogrel (eg, hypersensitivity, moderate or severe liver disease, active bleeding or bleeding history, history of intracranial hemorrhage)
* Need for oral anticoagulation therapy,
* Concomitant oral or IV therapy with strong CYP3A inhibitors (ketoconazole, itraconazole, voriconazole, telithromycin, clarithromycin, nefazodone, ritonavir, saquinavir, nelfinavir, indinavir, atazanavir, grapefruit juice N1 L/d), CYP3A substrates with narrow therapeutic indices (cyclosporine, quinidine), or strong CYP3Ainducers (rifampin/rifampicin, phenytoin, carbamazepine)
* Increased risk of bradycardia events
* Dialysis required
* Known clinically important thrombocytopenia
* Known clinically important anemia
* Any other condition that may put the patient at risk or influence study results in the investigators' opinion (eg, cardiogenic shock, severe hemodynamic instability, active cancer)
* Participant in another investigational drug or device study within 30 d
* Pregnancy or lactation
* Any condition that increases the risk for noncompliance or being lost to follow-up
* Involvement in the planning or conduct of the study
* Previous enrollment or randomization in this study
* Contraindications to fibrinolytic therapy including: 15

* Any prior intracranial hemorrhage
* Known structural cerebral vascular lesion (eg, Arterial Venous Malformation - AVM)
* Known malignant intracranial neoplasm (primary or metastatic)
* Ischemic stroke within 3 months
* Suspected aortic dissection
* Active bleeding or bleeding diathesis (excluding menses)
* Significant closed head trauma or facial trauma within 3 months
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital do Coracao

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Otavio Berwanger, MD,PhD

Role: STUDY_CHAIR

Hospital do Coracao

Helio P Guimaraes, MD,PhD

Role: STUDY_CHAIR

Hospital do Coracao

Leopoldo S Piegas, MD,PhD

Role: STUDY_CHAIR

Hospital do Coracao

Renato D Lopes, MD,PhD

Role: STUDY_CHAIR

Duke University

Jose C Nicolau, MD,PhD

Role: STUDY_CHAIR

Instituto do Coracao HC-FMUSP

Francisco A Fonseca, MD,PhD

Role: STUDY_CHAIR

Universidade Federal de São Paulo

Jose F Saraiva, MD,PhD

Role: STUDY_CHAIR

Hospital e Maternidade Celso Pierro

Carlos Tajer, MD,PhD

Role: STUDY_CHAIR

Investigación Independiente S.A.

Stephen Nicholls, MD,PhD

Role: STUDY_CHAIR

South Australian Health and Medical Research Institute

Shaun Goodman, MD,PhD

Role: STUDY_CHAIR

Canadian Heart Research Centre

Lixin Jiang, MD,PhD

Role: STUDY_CHAIR

Chinese Academy of Medical Sciences, Fuwai Hospital

Harvey White, MD,PhD

Role: STUDY_CHAIR

Auckland City Hospital - Auckland District Health Board

Germán Malaga, MD,PhD

Role: STUDY_CHAIR

Universidad Peruana Cayetano Heredia

Oleg Averkov, MD,PhD

Role: STUDY_CHAIR

Clinical Hospital #15 Clinical Hospital #15 named after O.M.Filatov, Moscow, Russia

Alexander Parkhomenko, MD,PhD

Role: STUDY_CHAIR

Institute of Cardiology - Emergency Cardiology Department

Christopher Granger, MD,PhD

Role: STUDY_CHAIR

Duke University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Interzonal General de Agudos Dr, José Penna

Bahía Blanca, , Argentina

Site Status

Hospital Alvarez

Buenos Aires, , Argentina

Site Status

Hospital Español de La Plata

La Plata, , Argentina

Site Status

Sanatorio Modelo de Quilmes

Quilmes, , Argentina

Site Status

Hospital Del Cruce Nestor Kishner

San Juan Bautista, , Argentina

Site Status

Hospital Zenón Santillan

San Miguel de Tucumán, , Argentina

Site Status

Flinders Medical Centre

Adelaide, , Australia

Site Status

Royal Adelaide Hospital

Adelaide, , Australia

Site Status

Cairns Hospital

Cairns, , Australia

Site Status

The Alfred Hospital

Melbourne, , Australia

Site Status

Mildura Hospital

Mildura, , Australia

Site Status

John Hunter Hospital

Newcastle, , Australia

Site Status

Fiona Stanley Hospital

Perth, , Australia

Site Status

Liverpool Hospital

Sydney, , Australia

Site Status

Townsville Hospital

Townsville, , Australia

Site Status

Wollongong Hospital

Wollongong, , Australia

Site Status

Hospital das Clínicas - UFMG

Belo Horizonte, , Brazil

Site Status

Hospital Lifecenter

Belo Horizonte, , Brazil

Site Status

Hospital Universitario Sao Jose

Belo Horizonte, , Brazil

Site Status

Santa Case de Belo Horizonte

Belo Horizonte, , Brazil

Site Status

Hospital de Base do Distrito Federal

Brasília, , Brazil

Site Status

Instituto de Cardiologia do Distrito Federal

Brasília, , Brazil

Site Status

Hospital de Clinicas da Universidade Estadual de Campinas - UNICAMP

Campinas, , Brazil

Site Status

Hospital e Maternidade Celso Pierro

Campinas, , Brazil

Site Status

Hospital e Clinica Sao Roque

Ipiaú, , Brazil

Site Status

Hospital e Pronto Socorro 28 de Agosto

Manaus, , Brazil

Site Status

Hospital de Messejana

Messejana, , Brazil

Site Status

Santa Casa de Montes Claros

Montes Claros, , Brazil

Site Status

Hospital Sao Vicente de Paulo

Passo Fundo, , Brazil

Site Status

Hospital Pronto Socorro e Maternidade Santa Lucia

Poços de Caldas, , Brazil

Site Status

Instituto de Cardiologia - Fundação de Cardiologia (ICFUC)

Porto Alegre, , Brazil

Site Status

Hospital Agamenon Magalhaes

Recife, , Brazil

Site Status

Hospital Municipal de Emergencia Albert Sabin

São Caetano do Sul, , Brazil

Site Status

Santa Casa de Sao Jose do Rio Preto

São José do Rio Preto, , Brazil

Site Status

Hospital do Coracao

São Paulo, , Brazil

Site Status

Hospital do Mandaqui

São Paulo, , Brazil

Site Status

Hospital Geral do Grajau / UNISA

São Paulo, , Brazil

Site Status

Hospital Municipal do Campo Limpo

São Paulo, , Brazil

Site Status

Hospital TotalCor

São Paulo, , Brazil

Site Status

PreventSenior

São Paulo, , Brazil

Site Status

Universidade Federal de Sao Paulo

São Paulo, , Brazil

Site Status

Cardiolima

Teresina, , Brazil

Site Status

Royal Alexandra Hospital

Edmonton, , Canada

Site Status

University of Alberta Hospital

Edmonton, , Canada

Site Status

Queen Elizabeth II Health Sciences Centre

Halifax, , Canada

Site Status

University Hospital / London Health Sciences Centre - Interventional Cardiology

London, , Canada

Site Status

Southlake Regional Health Centre - Interventional Cardiology

Newmarket, , Canada

Site Status

University of Ottawa Heart Institute

Ottawa, , Canada

Site Status

Peterborough Regional Health Centre

Peterborough, , Canada

Site Status

Inst Uni de Cardiologie et Pneumologie de Quebec

Québec, , Canada

Site Status

Regina General Hospital - Prairie Vascular Research Network (PVRN) - SETFAST Coordinating Centre (SCC)

Regina, , Canada

Site Status

New Brunswick Heart Centre Research Initiative

Saint John, , Canada

Site Status

Centre Hospitalier Universitaire de Sherbrooke

Sherbrooke, , Canada

Site Status

Thunder Bay Regional Health Sciences Centre - Cardiac Cath Lab

Thunder Bay, , Canada

Site Status

Centre Intégré Universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec

Trois-Rivières, , Canada

Site Status

Victoria Heart Institute Foundation

Victoria, , Canada

Site Status

St. Mary's General Hospital

Waterloo, , Canada

Site Status

Windsor Regional Hospital

Windsor, , Canada

Site Status

St. Boniface General Hospital

Winnipeg, , Canada

Site Status

Alxa League Central Hospital

Alashan, , China

Site Status

Anshan Changda Hospital

Anshan, , China

Site Status

Third affiliated hospital of Inner Mongolia medical university

Baotou, , China

Site Status

Urad Front Banner People's Hospital

Bayan Nur, , China

Site Status

The First Hospital of Fangshan District, Beijing

Beijing, , China

Site Status

Benxi Jinshan Hospital

Benxi, , China

Site Status

Binzhou City Center Hospital

Binzhou, , China

Site Status

Changyuan County People's Hospital

Changyuan, , China

Site Status

Chaoyang Second People's Hospital

Chaoyang, , China

Site Status

Dengfeng People's Hospital

Dengfeng, , China

Site Status

Dunhua Hospital

Dunhua, , China

Site Status

Fushun Mining Bureau General Hospital

Fushun, , China

Site Status

Gongyi People's Hospital

Gongyi, , China

Site Status

Hulunbuir People's Hospital

Harbin, , China

Site Status

Qi County People's Hospital

Hebi, , China

Site Status

Heze Municipal Hospital

Heze, , China

Site Status

Hunchun People's Hospital

Hunchun, , China

Site Status

Wen Country People´s Hospital

Jiaozuo, , China

Site Status

Laixi People's Hospital

Laixi, , China

Site Status

The Second Hospital of Liaocheng

Liaocheng, , China

Site Status

The Third People's Hospital of LiaoYang

Liaoyang, , China

Site Status

Dongfeng County Hospital

Liaoyuan, , China

Site Status

Houma People's Hospital

Linfen, , China

Site Status

Lingbao First People's Hospital

Lingbao, , China

Site Status

Ruyang People's Hospital

Luoyang, , China

Site Status

Anhui Province Mengcheng County, People's Hospital

Mengcheng, , China

Site Status

Puyang Zhongyuan Oil field General Hospital

Pujiang, , China

Site Status

Qinyang People's Hospital

Qinyang, , China

Site Status

Sanmenxia Central Hospital

Sanmenxia, , China

Site Status

Shangqiu Changzheng People's Hospital

Shangqiu, , China

Site Status

Shenyang Sujiatun District Central Hospital

Shenyang, , China

Site Status

Shenyang the Fourth Hospital of People

Shenyang, , China

Site Status

Xinmin People's Hospital

Shenyang, , China

Site Status

Jingxing County Hospital

Shijiazhuang, , China

Site Status

Laoting Hospital

Tangshan, , China

Site Status

Wuchuan People's Hospital

Wuchuan, , China

Site Status

Wuhai People's Hospital

Wuhai, , China

Site Status

Affiliated PuAi Hospital of Tongji Medical College

Wuhan, , China

Site Status

Wuyishan Municipal Hospital

Wuyishan, , China

Site Status

Qinghai Cardiovascular Hospital

Xining, , China

Site Status

Feng County People's Hospita

Xuzhou, , China

Site Status

Yongcheng People's Hospital

Yongcheng, , China

Site Status

Jiang Hua Yao Autonomous County People's Hospital

Yongzhou, , China

Site Status

The First People's Hospital of YueYang

Yueyang, , China

Site Status

Zhangye People's Hospital

Zhangye, , China

Site Status

Dancheng County People's Hospital

Zhoukou, , China

Site Status

Huaiyang County People's Hospital

Zhoukou, , China

Site Status

Foundation Cardiomet Cequin

Armenia, , Colombia

Site Status

Centro de Diagnostico Cardiologico Ltda

Cartagena, , Colombia

Site Status

Hawkes Bay Hospital

Hastings, , New Zealand

Site Status

Nelson Hospital

Nelson, , New Zealand

Site Status

Taranaki Hospital

New Plymouth, , New Zealand

Site Status

Rotorua Hospital

Rotorua, , New Zealand

Site Status

Tauranga Hospital

Tauranga, , New Zealand

Site Status

Thames Hospital

Thames, , New Zealand

Site Status

Whangarei Base Hopsital

Whangarei, , New Zealand

Site Status

Hospital Regional Lamabayeque

Chiclayo, , Peru

Site Status

Clínica Internacional

Lima, , Peru

Site Status

Clínica San Pablo

Lima, , Peru

Site Status

Hospital Cayetano Heredia

Lima, , Peru

Site Status

Hospital Hipólito Unanue

Lima, , Peru

Site Status

Regional State Budget Healthcare Institution Altai Regional Cardiology Dispensary

Barnaul, , Russia

Site Status

State Healthcare Institution "Belgorod regional clinical hospital named after Prelate Ioasaf

Belgorod, , Russia

Site Status

State Budget Healthcare Institution "Chelyabinsk regional clinical hospital #3"

Chelyabinsk, , Russia

Site Status

State Budget Healthcare Institution Leningrad region Gatchina Clinical Inter-district Hospital

Gatchina, , Russia

Site Status

State Healthcare Institution Irkutsk regional clinical hospital

Irkutsk, , Russia

Site Status

Kirov Regional State Budget Healthcare Institution Kirov City clinical hospital #1

Kirov, , Russia

Site Status

Regional State Budget Healthcare Institution Krasnoyarsk Regional Clinical Hospital

Krasnoyarsk, , Russia

Site Status

Municipal Healthcare Institution Lyubertsy regional Hospital #2

Lyubertsy, , Russia

Site Status

State Regional Budget Healthcare Institution Murmansk region Clinical Hospital named after P.A. Bayandin

Murmansk, , Russia

Site Status

State Budget Healthcare Institution Novosibirsk region City Clinical Hospital #34

Novosibirsk, , Russia

Site Status

Institution of the Russian academy of sciences Hospital of Pushchino Research Center of RAS

Pushchino, , Russia

Site Status

Municipal Budget Healthcare Institution Rostov-on-Don City Emergency Care Hospital

Rostov-on-Don, , Russia

Site Status

State Budget Healthcare Institution Ryazan region Regional Clinical Hospital

Ryazan, , Russia

Site Status

State Budget Educational Institution of Higher Professional Education "Smolensk State Medical University" Ministry of Healthcare of Russian Federation, clinical facility is State Budget Healthcare Institution "Smolensk regional clinical hospital"

Smolensk, , Russia

Site Status

Federal State Budget Science Institution "Science and Research Institute of Cardiology"

Tomsk, , Russia

Site Status

State Healthcare Institution of Tula Region "Tula regional clinical hospital

Tula, , Russia

Site Status

Tver Regional Clinical Hospital

Tver', , Russia

Site Status

State Budget Healthcare Institution Vladimir region City Hospital #4

Vladimir, , Russia

Site Status

Budget Healthcare Institution Voronezh region City Clinical Emergency Care Hospital #1

Voronezh, , Russia

Site Status

State Budget Healthcare Institution of Yaroslavl region "Regional clinical hospital"

Yaroslavl, , Russia

Site Status

Cherkasy Regional Cardiology Center, Department of Acute Heart Failure and Arrythmia

Cherkasy, , Ukraine

Site Status

Ivano-Frankivsk Regional Clinical Cardiological Dispensary, Department of Anestesiology and Intensive Care, SI"Ivano-Frankivsk National Medical University", Chair of Internal Medicine №2 and nurcering

Ivano-Frankivsk, , Ukraine

Site Status

Municipal Healthcare Institution "Kharkiv City Clinical Hospital #8", Cardiology Department for MI patients N1, Kharkiv Medical Academy of Postgraduate Education

Kharkiv, , Ukraine

Site Status

SI "National Institut of Therapy named after L.T. Malaya NAMS of Ukraine", Department of Acute Myocardial Infarction

Kharkiv, , Ukraine

Site Status

Kiev Oleksandrivsk Clinical Hospital, department of Cardiology Reanimation, National Medical University named after O.O. Bogomolets, Chair of Internal Medicine №2

Kyiv, , Ukraine

Site Status

Kyiv City Clinical Hospital #1, Department of Emergency Cardiology

Kyiv, , Ukraine

Site Status

Kyiv Emergency Care Hospital, Infarction Department

Kyiv, , Ukraine

Site Status

City Clinical Hospital # 1

Mykolaiv, , Ukraine

Site Status

MI "City Clinical Hospital N3 named after prof. K.J. Alejnikovoi", department of intensice cardiology care unit

Odesa, , Ukraine

Site Status

MI "Rivne Regional Clinical Hospital"

Rivne, , Ukraine

Site Status

Sumy regional Cardiology Dispensary

Sumy, , Ukraine

Site Status

MI "Regional Medical Center of Cardiovascular Diseases" of Zaporizhzhia Regional Council, Intensive Care Unit

Zaporizhzhya, , Ukraine

Site Status

Municipal Institution " Central city clinical hospital N1", cardiology department for MI patients

Zhytomyr, , Ukraine

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Argentina Australia Brazil Canada China Colombia New Zealand Peru Russia Ukraine

References

Explore related publications, articles, or registry entries linked to this study.

Cantor WJ, Tan M, Berwanger O, Lavi S, White HD, Nicolau JC, Dehghani P, Tajer CD, Lopes RD, Moia DDF, Nicholls SJ, Parkhomenko A, Averkov O, Brass N, Lutchmedial S, Malaga G, Damiani LP, Piegas LS, Granger CB, Goodman SG. Morphine and clinical outcomes in patients with ST segment elevation myocardial infarction treated with fibrinolytic and antiplatelet therapy: Insights from the TREAT trial. Am Heart J. 2022 Sep;251:1-12. doi: 10.1016/j.ahj.2022.05.005. Epub 2022 May 6.

Reference Type DERIVED
PMID: 35533724 (View on PubMed)

Berwanger O, Lopes RD, Moia DDF, Fonseca FA, Jiang L, Goodman SG, Nicholls SJ, Parkhomenko A, Averkov O, Tajer C, Malaga G, Saraiva JFK, Guimaraes HP, de Barros E Silva PGM, Damiani LP, Santos RHN, Paisani DM, Miranda TA, Valeis N, Piegas LS, Granger CB, White HD, Nicolau JC. Ticagrelor Versus Clopidogrel in Patients With STEMI Treated With Fibrinolysis: TREAT Trial. J Am Coll Cardiol. 2019 Jun 11;73(22):2819-2828. doi: 10.1016/j.jacc.2019.03.011. Epub 2019 Mar 18.

Reference Type DERIVED
PMID: 30898608 (View on PubMed)

Berwanger O, Nicolau JC, Carvalho AC, Jiang L, Goodman SG, Nicholls SJ, Parkhomenko A, Averkov O, Tajer C, Malaga G, Saraiva JFK, Fonseca FA, De Luca FA, Guimaraes HP, de Barros E Silva PGM, Damiani LP, Paisani DM, Lasagno CMR, Candido CT, Valeis N, Moia DDF, Piegas LS, Granger CB, White HD, Lopes RD; TREAT Study Group. Ticagrelor vs Clopidogrel After Fibrinolytic Therapy in Patients With ST-Elevation Myocardial Infarction: A Randomized Clinical Trial. JAMA Cardiol. 2018 May 1;3(5):391-399. doi: 10.1001/jamacardio.2018.0612.

Reference Type DERIVED
PMID: 29525822 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TREAT01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.